Codexis (CDXS) Accumulated Expenses (2010 - 2026)
Codexis (CDXS) recorded quarterly Accumulated Expenses of $5.4 million in Q1 2026, up 93.61% quarter-over-quarter from $2.8 million in Q4 2025, and down 16.1% on a YoY basis from $6.4 million in Q1 2025.
Codexis (CDXS) Accumulated Expenses (2010 - 2026) Analysis & Trends
Codexis' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 16.1% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (down 16.1% YoY), while the FY2025 annual figure was $2.8 million, down 75.74% from the prior year.
- Accumulated Expenses was $5.4 million for Q1 2026 at Codexis, up from $2.8 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $13.0 million in Q3 2022 to a low of $2.8 million in Q4 2025.
- Historically, Accumulated Expenses has averaged $7.6 million across 5 years, with a median of $6.8 million in 2022.
- Biggest YoY gain for Accumulated Expenses was 48.75% in 2025; the steepest drop was 75.74% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $11.5 million in 2022, then declined by 1.81% to $11.2 million in 2023, then increased by 1.46% to $11.4 million in 2024, then tumbled by 75.74% to $2.8 million in 2025, then surged by 93.61% to $5.4 million in 2026.
- The last three Accumulated Expenses figures came in at $5.4 million (Q1 2026), $2.8 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.36 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 9.68 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 6.39 Mn |
| Dec 31, 2024 | 11.41 Mn |
| Sep 30, 2024 | 6.51 Mn |
| Jun 30, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.37 Mn |
| Dec 31, 2023 | 11.25 Mn |
| Sep 30, 2023 | 8.80 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 6.61 Mn |
| Dec 31, 2022 | 11.45 Mn |
| Sep 30, 2022 | 12.99 Mn |
| Jun 30, 2022 | 7.73 Mn |
| Mar 31, 2022 | 6.84 Mn |
| Dec 31, 2021 | 12.58 Mn |
| Sep 30, 2021 | 15.93 Mn |
| Jun 30, 2021 | 9.08 Mn |